Trial
NCT04127695
A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
AbbVie
Collaborators
—
Condition
Parkinson's Disease
Intervention
ABBV-0805
Why stopped
Strategic considerations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-15